• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组人对 DNA 疫苗开发的历史反思。

One Group's Historical Reflections on DNA Vaccine Development.

机构信息

1 Department of Biology, Worcester State College, Worcester, Massachusetts.

2 Department of Medicine, University of Massachusetts Medical School , Worcester, Massachusetts.

出版信息

Hum Gene Ther. 2018 Sep;29(9):966-970. doi: 10.1089/hum.2018.066. Epub 2018 Aug 21.

DOI:10.1089/hum.2018.066
PMID:30129778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6152846/
Abstract

DNA vaccines were pioneered by several groups in the early 1990s. This article presents the reflections of one of these groups on their work with retroviral vectors in chickens that contributed to the discovery and early development of DNA vaccines. Although the findings were initially met with skepticism, the work presented here combined with that of others founded a new method of vaccination: the direct inoculation of purified DNA encoding the target antigen.

摘要

DNA 疫苗是 20 世纪 90 年代初由几个研究小组开创的。本文介绍了其中一个小组在研究鸡逆转录病毒载体方面的工作,这些工作为 DNA 疫苗的发现和早期发展做出了贡献。尽管最初这些发现受到了怀疑,但这里呈现的工作与其他研究结合起来,创立了一种新的疫苗接种方法:直接接种编码目标抗原的纯化 DNA。

相似文献

1
One Group's Historical Reflections on DNA Vaccine Development.一组人对 DNA 疫苗开发的历史反思。
Hum Gene Ther. 2018 Sep;29(9):966-970. doi: 10.1089/hum.2018.066. Epub 2018 Aug 21.
2
Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens.迈向新一代疫苗:细胞因子白细胞介素-12作为佐剂,在初免-加强免疫接种方案中增强对病原体的细胞免疫反应。
Histol Histopathol. 2001 Apr;16(2):655-67. doi: 10.14670/HH-16.655.
3
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).TLR1/2 激活在异源初免-加强免疫接种(DNA-MVA)中增强 CD8+ T 细胞反应,提供针对利什曼原虫(Viannia)的保护。
PLoS Negl Trop Dis. 2011 Jun;5(6):e1204. doi: 10.1371/journal.pntd.0001204. Epub 2011 Jun 14.
4
Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.用表达 HIV-1 病毒样颗粒的 DNA 和重组痘病毒载体对中国食蟹猴进行异源初免-加强-加强免疫接种。
Virol J. 2011 Sep 7;8:429. doi: 10.1186/1743-422X-8-429.
5
DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination.DNA 疫苗诱导的针对人类免疫缺陷病毒 gag 保守元件的长效细胞毒性 T 细胞在 DNA 或重组改良安卡拉痘苗接种后得到增强。
Hum Gene Ther. 2018 Sep;29(9):1029-1043. doi: 10.1089/hum.2018.065. Epub 2018 Jun 21.
6
Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.表达HIV抗原的甲病毒复制子DNA是用重组改良安卡拉痘苗病毒(MVA)或HIV gp140蛋白抗原进行加强免疫的优良初免疫苗。
PLoS One. 2015 Feb 2;10(2):e0117042. doi: 10.1371/journal.pone.0117042. eCollection 2015.
7
Progresses in DNA-based heterologous prime-boost immunization strategies.基于DNA的异源初免-加强免疫策略的进展
Methods Mol Biol. 2014;1143:61-90. doi: 10.1007/978-1-4939-0410-5_5.
8
Antigenicity of -Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.- 激活的 C 激酶抗原(LACK)在人外周血单核细胞中的抗原性,以及 pCI-neo-LACK 联合减毒表达 LACK 的痘苗病毒初免-加强免疫在仓鼠中的保护作用。
Front Immunol. 2018 Apr 23;9:843. doi: 10.3389/fimmu.2018.00843. eCollection 2018.
9
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.使用DNA随后接种重组改良安卡拉痘病毒的初免-加强免疫方案可在黑猩猩中诱导针对恶性疟原虫TRAP抗原的强烈细胞免疫反应。
Vaccine. 2001 Sep 14;19(32):4595-602. doi: 10.1016/s0264-410x(01)00260-2.
10
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.用异源DNA初免-改良安卡拉痘苗病毒加强的HIV-1疫苗方案接种后对保守的Gag区域的优先靶向作用
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00730-17. Print 2017 Sep 15.

引用本文的文献

1
Advances in the design and development of SARS-CoV-2 vaccines.SARS-CoV-2 疫苗的设计和开发进展。
Mil Med Res. 2021 Dec 16;8(1):67. doi: 10.1186/s40779-021-00360-1.
2
Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by Cell Factories.用于细胞工厂生产药用级质粒DNA、蛋白质和抗原的质粒复制子
Int J Mol Sci. 2021 Jan 30;22(3):1379. doi: 10.3390/ijms22031379.
3
Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future.争分夺秒获得免疫力:新冠病毒疫苗研发之旅及未来的经验教训。
Br J Clin Pharmacol. 2021 Sep;87(9):3408-3424. doi: 10.1111/bcp.14686. Epub 2021 Jan 6.
4
Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate.四价 DNA 疫苗候选物在小鼠体内诱导的登革病毒长期保护作用。
Zool Res. 2020 Jan 18;41(1):90-93. doi: 10.24272/j.issn.2095-8137.2020.016.

本文引用的文献

1
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.一种新型B亚型HIV-1疫苗组合的免疫原性:在未感染HIV-1的健康成年人中进行的1期随机安慰剂对照试验结果,该试验采用表达HIV-1 GM-CSF的DNA初免并联合改良安卡拉痘苗病毒疫苗加强免疫。
PLoS One. 2017 Jul 20;12(7):e0179597. doi: 10.1371/journal.pone.0179597. eCollection 2017.
2
Advances in Non-Viral DNA Vectors for Gene Therapy.用于基因治疗的非病毒DNA载体的进展
Genes (Basel). 2017 Feb 10;8(2):65. doi: 10.3390/genes8020065.
3
Rapid development of a DNA vaccine for Zika virus.寨卡病毒DNA疫苗的快速研发。
Science. 2016 Oct 14;354(6309):237-240. doi: 10.1126/science.aai9137. Epub 2016 Sep 22.
4
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.DNA 疫苗攻击癌症:提高免疫原性和疗效的策略。
Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24.
5
DNA immunization as a technology platform for monoclonal antibody induction.DNA免疫作为诱导单克隆抗体的技术平台。
Emerg Microbes Infect. 2016 Apr 6;5(4):e33. doi: 10.1038/emi.2016.27.
6
A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.一条不依赖cGAS的STING/IRF7通路介导DNA疫苗的免疫原性。
J Immunol. 2016 Jan 1;196(1):310-6. doi: 10.4049/jimmunol.1501836. Epub 2015 Nov 20.
7
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.一种合成的共识抗刺突蛋白DNA疫苗可在非人灵长类动物中诱导针对中东呼吸综合征冠状病毒的保护性免疫。
Sci Transl Med. 2015 Aug 19;7(301):301ra132. doi: 10.1126/scitranslmed.aac7462.
8
The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.滤泡辅助性T细胞和生发中心在HIV-1 gp120 DNA初免及gp120蛋白加强疫苗接种中的作用
Hum Vaccin Immunother. 2014;10(7):1985-92. doi: 10.4161/hv.28659.
9
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.DNA 和表达 HIV-1 病毒样颗粒的重组改良安卡拉牛痘疫苗诱导的免疫应答的特异性和 6 个月持久性。
J Infect Dis. 2014 Jul 1;210(1):99-110. doi: 10.1093/infdis/jiu003. Epub 2014 Jan 7.
10
Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.保护性 DNA 疫苗接种诱导针对马尔堡和埃博拉的广谱细胞毒性 T 细胞。
Mol Ther. 2013 Jul;21(7):1432-44. doi: 10.1038/mt.2013.61. Epub 2013 May 14.